Endometriosis

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
4 Unique IMPs
1 Commercial trials
Drug classes (ATC)
G Urology/Gynaecology (ATC G) 2
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Phase II: 2 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

2 trials
  • Chugai Pharmaceutical Co. Ltd. Commercial
    AMY109; DESOGESTREL
    2023-507289-14-00 3 countries 2024 n=80
    Ended
  • Centre Hospitalier Universitaire De Nantes Academic
    FLUOROESTRADIOL F-18
    2025-520637-24-00 1 country 2026 n=20
    Recruiting

Phase IV

1 trial
  • Turku University Central Hospital Academic
    CABERGOLINE
    2022-500792-31-00 1 country n=80
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Chugai Pharmaceutical Co. Ltd. Commercial 1 Phase II 0
Centre Hospitalier Universitaire De Nantes Academic 1 Phase II 1
Turku University Central Hospital Academic 1 Phase IV 0
New trials by year
2024
1
2026
1
← All indication landscapes